Treatment preference among patients with spinal muscular atrophy (SMA): a discrete choice experiment.

Improvements in motor/breathing function, broad indication, oral or one-time infusion, and minimal risk were preferred treatment attributes. Treatment decisions should be made in clinical context and be tailored to patient needs.